249 articles in this topic
Researchers found a rogue RNA molecule that fuels liver cancer by boosting protein synthesis, opening new treatment pathways.
New research identifies BRD8 protein as both a predictor of treatment response and potential target for overcoming drug resistance.
New research reveals sex-specific pathways that help brain tumors escape immune detection, with implications for personalized treatment.
Scientists discover that enhancing protein cleanup in immune cells prevents exhaustion and dramatically improves cancer immunity.
New deep learning tool finds immune targets in deadly brain tumors with 90% accuracy using lab-grown tumor models.
Scientists discover how a small RNA molecule enhances ferroptosis to fight liver cancer, revealing new therapeutic targets.
Pralsetinib demonstrates remarkable efficacy against rare RET fusion lung cancers with manageable side effects.
New molecular analysis tool could revolutionize treatment decisions for chronic myelomonocytic leukemia patients.
Novel BRAF inhibitor mosperafenib demonstrates safety and efficacy in patients with advanced cancers, including those resistant to prior treatments.
Study reveals cancer can progress on imaging scans even when PSA levels remain stable, challenging current monitoring approaches.
New guidelines address how monetary transfers can ethically support cancer patients in clinical trials while avoiding coercion.
Scientists reveal how to reprogram immune cells that normally help tumors grow to instead become powerful cancer killers.
